Drug Information Journal - March 2009 - (Page 227) 2009 EUROMEETING 227 2009 EuroMeeting Student Poster Abstracts Following are the Student Poster Session Abstracts that have been accepted as of the press date of this issue. The student posters will be on display at the DIA 21st Annual Euro Meeting, March 23–25, Internationales Congress Centrum, Berlin, Germany. The poster review committee will select the winning posters on Tuesday, March 24, and the winning authors will receive a EuroMeeting Student Poster prize. A single blind, placebo controlled clinical trial to evaluate the short term effect of Bacopa mooneiri formulation in enhancing the psychomotor performance of normal healthy volunteers using mindomatics software Ankur Kripa Shankar Pandey Bhandup, Mumbai, India Objective To assess short term effect of a classical Ayurvedic formulation of Bacopa mooneiri in calorified butter on psychomotor performance in healthy volunteers using a standardized and validated computerised tests and to compare the results with vehicle control, chlorpheniramine maleate (CPM) and coffee. Method Institutional Ethics Committee approval taken, 20 normal healthy volunteers screened, recruited and informed consent taken. Volunteers trained, tests performed—basal with CPM (75 mg) and coffee (150 mg powder). Study drug and vehicle control administered (2 tsp once daily for 1 month) and tests performed. Results Formulation betters motor performance, recent memory, attention, integration, co-ordination, sensory-motor performance significantly compared to vehicle and CPM, while effects were akin to coffee. It showed improvement in central integration and visual motor co-ordination, though not significant by stats. Conclusion This formulation of 4 potential drugs in calorified butter has a potential to improve the psychomotor performance which needs to be confirmed further through trials in cognitive disorders. Our results document for the first time that an Ayurvedic formulation improves psychomotor performance. Method Literature research using MEDLINE, cross-reference of published data and review of World Health Organization—Pharmacovigilance transcripts, surgery and dentistry transcripts pertaining to pharmacovigilance. Results Pharmacovigilance system is in its infancy in surgery and dentistry. The target health care professionals are least likely to report an adverse drug reaction. Reasons and recommendations are put forward. Three tier approach and six sigma methodology will be presented to overcome the issue. Conclusion With growing awareness of pharmacovigilance in various fields of medicine, surgery/dentistry can no longer remain an exception. In the transition from medical school to surgery/dental clinic a subtle shift must occur from emphasizing pharmacokinetics to appreciating pharmacodynamics. Genetic and environmental factors determining clinical outcomes associated with warfarin therapy: a prospective study Andrea Jorgensen University of Liverpool, United Kingdom Objective To evaluate the impact of environmental and genetic factors on warfarin response in patients being initiated on warfarin, a prospective study of 1,000 patients was undertaken. Method Patients being initiated onto warfarin were genotyped across 29 genes and several clinical factors were assessed. Follow-up was for up to six months. Outcomes were chosen to capture response in terms of efficacy and toxicity, during both the initiation and maintenance phases of treatment. Results In the univariate and multiple regression analyses undertaken to investigate association, variants within genes CYP2C9 and VKORC1 were the most significant. Associations with other genes were also detected, however a significant proportion of variability in dose requirements remained unexplained. Conclusion CYP2C9 was most important during initiation, whilst VKORC1 was most important during maintenance. As maintenance dose Pharmacovigilance in surgery and dentistry: overlooked or axiomatic? Sohil A Khan Research Scholar, School of Pharmacy, University of Queensland, Brisbane, Australia Objective To review the status of pharmacovigilance system in less explored and ignored area of surgery and dentistry with recommendation for effective functioning. Drug Information Journal, Vol. 42, pp. 227–231, 2009 • 0092-8615/2009 Printed in the USA. All rights reserved. Copyright © 2009 Drug Information Association, Inc.
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.